5 NYSE Healthcare Stocks With The Highest ROI

Below are the top NYSE stocks in the healthcare sector in terms of return on investment. The trailing-twelve-month return on investment at Novo Nordisk A/S (ADR) NVO is 65.50 percent. Novo Nordisk's revenue for the same period is $14.00 billion. The trailing-twelve-month return on investment at InVitae Corp NVTA is 59.20 percent. InVitae's revenue for the same period is $2.70 million. The trailing-twelve-month return on investment at USANA Health Sciences, Inc. USNA is 33.50 percent. USANA Health Sciences' revenue for the same period is $827.40 million. The trailing-twelve-month return on investment at Taro Pharmaceutical Industries Ltd. TARO is 30.40 percent. Taro Pharmaceutical's revenue for the same period is $862.90 million. The trailing-twelve-month return on investment at Edwards Lifesciences Corp EW is 29.10 percent. Edwards Lifesciences' revenue for the same period is $2.39 billion.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Trading IdeasHealthcare Sector
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!